Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q81606403> ?p ?o ?g. }

Showing items 1 to 87 of 87 with 100 items per page.

Q81606403 description "article scientifique publié en 2005" @default.
Q81606403 description "artículu científicu espublizáu en mayu de 2005" @default.
Q81606403 description "im Mai 2005 veröffentlichter wissenschaftlicher Artikel" @default.
Q81606403 description "scientific article published on 01 May 2005" @default.
Q81606403 description "wetenschappelijk artikel" @default.
Q81606403 description "наукова стаття, опублікована в травні 2005" @default.
Q81606403 name "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 name "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 type Item @default.
Q81606403 label "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 label "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 prefLabel "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 prefLabel "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 P1433 Q81606403-063381F3-BEE4-4013-9129-F86029280186 @default.
Q81606403 P1476 Q81606403-C7A7C269-F9E3-41F2-B8FC-48D9CA034246 @default.
Q81606403 P2093 Q81606403-049399C5-5E1D-42BC-B8E8-A6DBF3E35E5C @default.
Q81606403 P2093 Q81606403-17E6AED9-59E2-402E-AA1E-26CE60CB6014 @default.
Q81606403 P2093 Q81606403-34EB9135-BEEB-4BE9-BB38-5375F85BF26A @default.
Q81606403 P2093 Q81606403-3E96B5C2-77E5-425A-920D-0F1C31BA4C31 @default.
Q81606403 P2093 Q81606403-7553C020-9CA3-47AE-AA0B-952E60B166A2 @default.
Q81606403 P2093 Q81606403-84A00202-8D07-4FBD-BCEF-B5ABF92E7CF8 @default.
Q81606403 P2860 Q81606403-01BACCCD-9114-4E74-8BE9-8E58D03FB986 @default.
Q81606403 P2860 Q81606403-0494F38F-BCC7-43CD-9F0F-98AE06425D6E @default.
Q81606403 P2860 Q81606403-0C33F8C5-7541-495A-9339-08DAB4E8ABEA @default.
Q81606403 P2860 Q81606403-10CDC218-8735-4F58-BD70-DA652FA2F87A @default.
Q81606403 P2860 Q81606403-3434EDF1-2801-452D-BBC4-E9FFB2E1E096 @default.
Q81606403 P2860 Q81606403-357C8E9D-0CA2-4D6D-9CE8-26766FDF11FB @default.
Q81606403 P2860 Q81606403-4153B6AE-8D96-431D-B56B-70B09D14FDC3 @default.
Q81606403 P2860 Q81606403-45A78F47-C603-4FF6-BAF6-8BA386322565 @default.
Q81606403 P2860 Q81606403-69D893F0-40F3-4252-822C-031887C02E16 @default.
Q81606403 P2860 Q81606403-7D03F416-18DB-4F53-AD33-8243C6FDB4C8 @default.
Q81606403 P2860 Q81606403-8FD0C1F8-3902-4553-8E26-11A71233E8CE @default.
Q81606403 P2860 Q81606403-905E4271-4D94-4DA4-88DE-20D740D1FF16 @default.
Q81606403 P2860 Q81606403-95AD8631-5057-450E-9F3F-421C4C601626 @default.
Q81606403 P2860 Q81606403-97C270CF-829B-4D60-9D27-1C0CDE58E92A @default.
Q81606403 P2860 Q81606403-D1FDCA40-2551-423D-AB0D-45A0AFF032DE @default.
Q81606403 P2860 Q81606403-E1CB5B9F-DEEF-4C7F-B3E3-27A606B97752 @default.
Q81606403 P2860 Q81606403-E2A93FF2-9341-49D4-A014-9E8565E00A6C @default.
Q81606403 P2860 Q81606403-EC69613E-6EB2-43E2-9675-B50D37EF8B0D @default.
Q81606403 P2888 Q81606403-6F32212E-78C6-4FA2-9DB2-2AB3125E709C @default.
Q81606403 P304 Q81606403-CDC8DC6E-32D4-4CB6-B845-78805946F32D @default.
Q81606403 P31 Q81606403-D0BA20EE-70E7-4672-9FD6-3F12E71D1CFD @default.
Q81606403 P356 Q81606403-E9F57994-A395-40E2-AA3C-0CEA6DD32D70 @default.
Q81606403 P433 Q81606403-53E55818-C392-4CF2-8B6F-6AA84AAD59A1 @default.
Q81606403 P478 Q81606403-D03F37C9-D4F8-498C-9DBF-B48BA9F5F175 @default.
Q81606403 P577 Q81606403-76913F2E-3F87-41FF-9D61-8CE6FFE72A7C @default.
Q81606403 P6179 Q81606403-E5F90035-8248-4B3B-B4B7-51C3173FA7C2 @default.
Q81606403 P698 Q81606403-C53FEF44-E077-4FC1-B61B-0515C1E52F28 @default.
Q81606403 P921 Q81606403-C993E0FF-C3BE-477B-AA8D-53E29547EA7E @default.
Q81606403 P356 SJ.BMT.1704936 @default.
Q81606403 P698 15806133 @default.
Q81606403 P1433 Q4941523 @default.
Q81606403 P1476 "Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide" @default.
Q81606403 P2093 "Ackerstein A" @default.
Q81606403 P2093 "Bitan M" @default.
Q81606403 P2093 "Or R" @default.
Q81606403 P2093 "Samuel S" @default.
Q81606403 P2093 "Shapira MY" @default.
Q81606403 P2093 "Slavin S" @default.
Q81606403 P2860 Q32052665 @default.
Q81606403 P2860 Q34163031 @default.
Q81606403 P2860 Q34571931 @default.
Q81606403 P2860 Q43848111 @default.
Q81606403 P2860 Q44231492 @default.
Q81606403 P2860 Q44452155 @default.
Q81606403 P2860 Q44773044 @default.
Q81606403 P2860 Q58455856 @default.
Q81606403 P2860 Q64038880 @default.
Q81606403 P2860 Q67488659 @default.
Q81606403 P2860 Q69876471 @default.
Q81606403 P2860 Q70051817 @default.
Q81606403 P2860 Q71762882 @default.
Q81606403 P2860 Q73117300 @default.
Q81606403 P2860 Q73181412 @default.
Q81606403 P2860 Q74389060 @default.
Q81606403 P2860 Q77409054 @default.
Q81606403 P2860 Q85697496 @default.
Q81606403 P2888 sj.bmt.1704936 @default.
Q81606403 P304 "953-958" @default.
Q81606403 P31 Q13442814 @default.
Q81606403 P356 "10.1038/SJ.BMT.1704936" @default.
Q81606403 P433 "10" @default.
Q81606403 P478 "35" @default.
Q81606403 P577 "2005-05-01T00:00:00Z" @default.
Q81606403 P6179 "1044124485" @default.
Q81606403 P698 "15806133" @default.
Q81606403 P921 Q65592366 @default.